JAMES HENRY: Open Payments
NPI 1982165692 · CLARKSVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$202 in 11 payments from 8 companies in 2025. Trend: 2023 $130 · 2024 $413 · 2025 $202
Food & beverage: $202
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 2 | $55 |
| Novo Nordisk Inc | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Lundbeck LLC | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Organon LLC | 1 | $3 |
Products named: Ohtuvayre, AIRSUPRA, REXULTI, UBRELVY, CAPLYTA, Ozempic, GVOKE HYPOPEN, JADA SYSTEM.
Industry payments across AR — which companies pay providers there.
